Cargando…
Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer
Breast cancer (BrC) is the most frequent malignancy and the leading cause of cancer death among women worldwide. Approximately 70% of BrC are classified as luminal-like subtype, expressing the estrogen receptor. One of the most common and effective adjuvant therapies for this BrC subtype is endocrin...
Autores principales: | Amorim, Maria, Lobo, João, Fontes-Sousa, Mário, Estevão-Pereira, Helena, Salta, Sofia, Lopes, Paula, Coimbra, Nuno, Antunes, Luís, Palma de Sousa, Susana, Henrique, Rui, Jerónimo, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749838/ https://www.ncbi.nlm.nih.gov/pubmed/31572437 http://dx.doi.org/10.3389/fgene.2019.00815 |
Ejemplares similares
-
Digital imaging-assisted quantification of H3K27me3 immunoexpression in luminal A/B-like, HER2-negative, invasive breast cancer predicts patient survival and risk of recurrence
por: Fontes-Sousa, Mário, et al.
Publicado: (2020) -
Overexpression of circulating MiR-30b-5p identifies advanced breast cancer
por: Estevão-Pereira, Helena, et al.
Publicado: (2019) -
A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA
por: Salta, Sofia, et al.
Publicado: (2018) -
Decoding the usefulness of non-coding RNAs as breast cancer markers
por: Amorim, Maria, et al.
Publicado: (2016) -
DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis
por: Salta, Sofia, et al.
Publicado: (2023)